###begin article-title 0
Gene-Gene Interactions in the Folate Metabolic Pathway and the Risk of Conotruncal Heart Defects
###end article-title 0
###begin p 1
Academic Editor: Janet Sinsheimer
###end p 1
###begin p 2
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 893 894 893 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 440 <span type="species:ncbi:9606">Children</span>
Conotruncal and related heart defects (CTRD) are common, complex malformations. Although there are few established risk factors, there is evidence that genetic variation in the folate metabolic pathway influences CTRD risk. This study was undertaken to assess the association between inherited (i.e., case) and maternal gene-gene interactions in this pathway and the risk of CTRD. Case-parent triads (n = 727), ascertained from the Children's Hospital of Philadelphia, were genotyped for ten functional variants of nine folate metabolic genes. Analyses of inherited genotypes were consistent with the previously reported association between MTHFR A1298C and CTRD (adjusted P = .02), but provided no evidence that CTRD was associated with inherited gene-gene interactions. Analyses of the maternal genotypes provided evidence of a MTHFR C677T/CBS 844ins68 interaction and CTRD risk (unadjusted P = .02). This association is consistent with the effects of this genotype combination on folate-homocysteine biochemistry but remains to be confirmed in independent study populations.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Congenital heart defects (CHDs) are a heterogeneous group of malformations with a birth prevalence that approaches 1 per 100 [1]. In addition to being the most common type of structural birth defect, CHDs have a major impact on pediatric morbidity and mortality [2]. Although CHDs can occur in association with several known teratogenic (e.g., anticonvulsants and maternal pregestational diabetes) and genetic (e.g., 22q11 deletion and Alagille) syndromes [3, 4], most CHDs (approximately 80%) appear to be nonsyndromic [5] and are thought to have a complex etiology involving interactions between several factors. However, relatively little is known about the specific risk factors for non-syndromic CHDs, and there are currently no strategies for reducing the public health impact of these conditions [3].
###end p 4
###begin p 5
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The identification of CHD risk factors is complicated by several issues. For example, since CHDs develop during gestation, studies aimed at identifying genetic risk factors should consider the effects of both the maternal genotype and the inherited genotype (i.e., the genotype inherited by the case) [6]. Further, as CHDs are complex conditions, the identification of risk factors may require the simultaneous assessment of multiple factors (e.g., gene-gene interactions). In addition, since CHDs are a heterogeneous group of conditions, analyses may need to be restricted to subgroups of phenotypes that are likely to be relatively homogeneous [7].
###end p 5
###begin p 6
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 544 545 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 923 928 <span type="species:ncbi:9606">women</span>
The present study was undertaken to extend our studies of the relationship between conotruncal and related heart defects (CTRD), which are thought to comprise a relatively homogenous subset of CHDs, and variation within genes in the folate metabolic pathway. This pathway was selected for analysis given evidence that, similar to neural tube defects, the risk of CHDs in general, and of CTRD in particular, is influenced by maternal folate status (reviewed in [3]), as well as variation within genes that comprise the folate metabolic pathway [8-11]. As there are few other clues regarding the causes of non-syndromic CTRD, additional studies of the association between genetic variation within the folate metabolic pathway and the risk of CTRD are strongly warranted. Moreover, confirmation of an association between CTRD and the folate metabolic pathway would suggest potential, targeted risk reduction strategies (e.g., women with high-risk genotypes could be targeted for interventions aimed at increasing folic acid supplementation). We have previously analyzed these data using a sequential (i.e., SNP-by-SNP) approach to assess associations between CTRD and both the maternal genotype and the inherited genotype. Here, we summarize additional analyses that consider potential maternal and inherited gene-gene interaction effects, as well as heterogeneity in the effect of the inherited genotype across the CTRD component phenotypes.
###end p 6
###begin title 7
2. Materials and Methods
###end title 7
###begin title 8
2.1. Study Subjects
###end title 8
###begin p 9
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 177 185 <span type="species:ncbi:9606">Children</span>
###xml 236 244 <span type="species:ncbi:9606">Patients</span>
Details of this family-based, case-parent triad study have been provided previously [8]. Briefly, individuals with a CTRD were ascertained through the clinical practices of the Children's Hospital of Philadelphia between 1997 and 2007. Patients of either sex and of any race/ethnicity, with a diagnosis of tetralogy of Fallot (TOF), D-transposition of the great arteries (D-TGA), double outlet right ventricle (DORV), truncus arteriosus (TA), interrupted aortic arch (IAA), conoventricular or posterior malalignment type ventricular septal defect (VSD), or an isolated aortic arch anomaly (AAA) were eligible to be cases in this study. Medical records were reviewed to confirm the cardiac diagnosis for each case. Potential subjects who had a recognized syndrome, including the 22q11 deletion syndrome, were excluded so as to reduce etiologic heterogeneity among the cases.
###end p 9
###begin p 10
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Blood samples were collected from cases prior to a blood transfusion at the time of surgical or other interventions. Blood, buccal, or saliva samples were collected from each participating parent, however, participation of both parents was not required [12].
###end p 10
###begin title 11
2.2. Laboratory Methods
###end title 11
###begin p 12
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHMT</italic>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP1</italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTR</italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTRR</italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHMT</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> TCN2</italic>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CBS</italic>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHFR</italic>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1106 1107 1106 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
DNA, regardless of sample type, was extracted using the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN) according to the manufacturer's protocol. Ten polymorphisms from nine genes in the folate metabolic pathway, including eight single nucleotide polymorphisms: BHMT G742A (rs3733890), MCP1 A251G (rs1024611), MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087), MTRR A66G (rs18013940), SHMT C1420T (rs1979277), TCN2 C777G (rs1801198) and two insertion/deletion alleles:  CBS 844ins68 and DHFR intron 1 19-base pair deletion, were genotyped as previously described [8]. Each of these variants has been shown to influence the function of the resulting gene product [13-22]. Genotyping of single nucleotide polymorphisms was conducted in the High-Throughput Genotyping Core Laboratory at the Molecular Diagnosis and Genotyping Facility at the University of Pennsylvania, using the ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, California). The insertion/deletion polymorphisms were genotyped using published polymerase chain reaction-based assays [8, 23] and visualized on agarose gels.
###end p 12
###begin title 13
2.3. Statistical Methods
###end title 13
###begin p 14
###xml 111 116 <span type="species:ncbi:9606">child</span>
###xml 174 179 <span type="species:ncbi:9606">child</span>
All statistical analyses included a single case per family (e.g., in a family with two affected offspring, one child was randomly selected to serve as the case and the other child was not included in the study). None of the cases were known to be related. Case and parental characteristics were summarized using counts and proportions. For each analyzed genetic variant, the proportion of samples for which a genotype could not be assigned, the proportion of samples that yielded discrepant results on repeated genotypes, and the proportion of triads that had genotype combinations that were incompatible with Mendelian inheritance were determined. For each sample, the number of genotyping failures (i.e., genotypes that could not be assigned or were discrepant across repeated genotypes) was determined. These analyses were performed using SAS version 9.1 (SAS Institute Inc).
###end p 14
###begin p 15
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Multifactor dimensionality reduction-phenomics (MDR-P) [24] was used to assess the association between inherited gene-gene interactions and CTRD and to determine whether the association was influenced by heterogeneity across the seven specific CTRD component phenotypes included in the case definition [24]. MDR-P uses a permutation method to estimate P-values that are adjusted for multiple testing. All one-, two-, three-, and four-locus models derived from the ten genotyped folate metabolic genetic variants were assessed. These analyses were implemented with the computer program MDR-Phenomics [24], using data from triads with complete genotype data for all variants included in a given model.
###end p 15
###begin p 16
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHMT</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCP1</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHMT</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 500 501 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Given that MDR-P uses information on the transmission of alleles from parents to an affected offspring to assess associations, this method cannot be used to assess maternal gene-gene interactions in case-parent triad data. Consequently, a case-only approach was used to assess maternal gene-gene interactions [25]. Specifically, for case mothers, all pairwise gene-gene combinations were assessed (e.g., BHMT G742A/MCP1 A251G, BHMT G742A/MTHFR C677T). Chi-square tests were used to obtain unadjusted P-values. All case-only analyses were restricted to data from white mothers due to the potential for population stratification bias [26]. These analyses were performed using SAS version 9.1 (SAS Institute Inc).
###end p 16
###begin p 17
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 450 459 450 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inherited</italic>
###xml 507 515 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maternal</italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1220 1221 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Maternal gene-gene combinations that were associated with CTRD in the case-only analyses (i.e., unadjusted P < .05) were investigated using log-linear models for joint effects in order to obtain effect estimates [27]. To test the no-interaction null hypothesis, we calculated a 2-degree-of-freedom likelihood ratio test (LRT) statistic as twice the difference of the log likelihoods for the log-linear model that included two parameters indexing the inherited genotype for SNP1, two parameters indexing the maternal genotype for SNP1, and two interaction terms representing the product of maternal SNP1-SNP2 pairwise genotypes and a reduced model that excluded the interaction terms. These analyses were run using LEM [28], a program for log-linear analysis with missing data that allows information from triads that have not been completely genotyped (e.g., father not available) to be included in the analysis for any given variant [12]. To reduce concerns regarding possible mating stratification bias [26, 29], only data from triads in which both parents were reported to be white were used in these analyses. Given the exploratory nature of these analyses, both unadjusted and adjusted (i.e., Bonferroni corrected) P-values are presented.
###end p 17
###begin title 18
3. Results
###end title 18
###begin p 19
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 146 153 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
Details of the study sample have been provided elsewhere [8]. Briefly, there were 727 case-parent triads in which the case individual had a CTRD (Table 1). The most common diagnoses among the cases were tetralogy of Fallot (38.4 percent), D-transposition of the great arteries (20.9 percent), and ventricular septal defect (20.1 percent). There was a predominance of males among the cases (59.2 percent), and the majority of parents were reported to be white (72.2 percent).
###end p 19
###begin p 20
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 794 795 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
DNA samples were available for 1991 members of the study triads (i.e., 537 complete triads and 190 case-parent pairs). Genotype call rates for these 1991 samples ranged from 96% to 98% for each variant; the proportion of samples that provided discrepant results on repeat genotypes ranged from 0% to 0.8%; and the proportion of triads with genotype combinations that were incompatible with Mendelian inheritance ranged from 0.7% to 2.5% (n = 5-19 families) per variant. On the basis of these results, all of the genotypes were considered to be of sufficiently high quality to include in the subsequent statistical analyses. However, all genotype data from families that included at least one genotype combination that was incompatible with Mendelian inheritance were omitted from all analyses (n = 225 samples from 75 triads with a Mendelian inconsistency for one or more variant). In addition, all genotype data from individual samples that failed (i.e., no genotype called) or provided discrepant results on repeat genotyping for four or more of the genotyped variants were omitted from all analyses (n = 55 samples). After the above-mentioned exclusions, 652 families (90%) were available for analysis, and the number of useable genotypes for each of the variants ranged from 1685 to 1715.
###end p 20
###begin p 21
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTR</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In our previous SNP-by-SNP analyses of these data [8], three of the ten folate metabolic variants were found to be associated with CTRD at P (unadjusted) < .05: MTR A2756G (maternal effect, P = .04), CBS 844ins68 (inherited effect, P = .05), and MTHFR A1298C (inherited effect, P = .002). However, only the association with the inherited MTHFR A1298C genotype remained significant when the false discovery rate was controlled at 0.05 (unadjusted P = .0021 < .0025).
###end p 21
###begin p 22
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 456 463 456 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
MDR-P was used to evaluate inherited gene-gene interactions and heterogeneity across the seven CTRD component phenotypes. Using this approach, the only model achieving significance was the one-locus model for the MTHFR A1298C variant (adjusted P = .02). There was no evidence of heterogeneity in the association of this variant across the seven CTRD component phenotypes, and no other one-, two-, three-, or four-locus model had an adjusted P value < .05 (Table 2).
###end p 22
###begin p 23
###xml 104 111 104 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 325 326 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 501 504 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 730 733 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
The case-only approach was used to assess the association of CTRD with maternal gene-gene interactions (Table 3). Using this approach, two maternal gene-gene combinations were associated with CTRD with unadjusted P values less than .05: MTHFR C677T/CBS 844ins68 (unadjusted P = .01) and MTHFR A1298C/CBS 844ins68 (unadjusted P = .02). Based on the data presented in Table 4, the MTHFR 677 TT genotype is over-represented and the MTHFR 1298 CC genotype is under-represented among case-mothers with the CBS NN genotype. As these two MTHFR variants are in strong linkage disequilibrium [8, 30, 31], and given prior evidence that homocysteine levels are influenced by a MTHFR C677T/CBS 844ins68 interaction [32], only the MTHFR C677T/CBS interaction was evaluated using log-linear analyses.
###end p 23
###begin p 24
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 683 686 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 758 761 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 782 789 782 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab5">Table 5</xref>
###xml 807 808 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 937 940 937 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 1142 1143 1142 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 635 640 <span type="species:ncbi:9606">child</span>
In the log-linear analyses, the maternal CBS 844ins68 IN and II genotypes were combined, due to the small number of II genotypes (n = 4), and the two resulting categories (NN versus IN + II) were used to stratify the data. An unrestricted model, which provides effect estimates for heterozygotes and for rare homozygotes, was fitted to the maternal MTHFR C677T genotype data. For these analyses, data from mothers who were genotyped for the MTHFR C677T but not the CBS 844ins68 variant were excluded (n = 2). Mothers who were CBS NN and MTHFR 677 TT had a 1.85-fold (95 percent confidence interval: 1.13, 3.02) higher risk of having a child with a CTRD as compared to those who were CBS NN and MTHFR 677 CC. This association was not seen in mothers with the CBS IN or II genotypes (Table 5). The unadjusted P-value for the LRT of heterogeneity of the effect of the maternal MTHFR C677T genotype across categories defined by the maternal CBS 844ins68 insertion genotype was 0.02, but this association was not significant at the 0.05 level, after applying the Bonferroni correction for the evaluation of all 44 maternal gene-gene combinations (P = .02 > .001).
###end p 24
###begin title 25
4. Discussion
###end title 25
###begin p 26
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
We have previously reported that the inherited MTHFR A1298C genotype is associated with the risk of CTRD, and others have observed a similar association in CHD samples including, but not limited to CTRD [8, 9]. Our results using MDR-P are consistent with these previous findings and provide evidence that this association is similar across the seven component CTRD phenotypes (TOF, D-TGA, VSD, DORV, AAA, TA, and IAA). However, based on these analyses, there is no evidence that the inherited MTHFR A1298C genotype influences the risk of CTRD via interactions with the other measured genotypes, or that other measured folate metabolic genotype combinations influence CTRD risk.
###end p 26
###begin p 27
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 541 544 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 855 858 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 384 389 <span type="species:ncbi:9606">women</span>
###xml 460 465 <span type="species:ncbi:9606">child</span>
###xml 489 494 <span type="species:ncbi:9606">women</span>
The SNP-by-SNP analyses of these data provided little evidence that the risk of CTRD is influenced by maternal genotype for any of the measured variants [8]. However, analyses of pairwise maternal gene-gene combinations suggested that a maternal MTHFR C677T/CBS 844ins68 interaction is associated with the risk of CTRD in offspring. Specifically, based on our analyses of these data, women with the MTHFR TT genotype appear to be at increased risk of having a child with CTRD, relative to women with CC genotype, only if they also carry the CBS NN genotype. Although this association did not achieve statistical significance after correction for multiple testing, it is in line with studies showing that the high homocysteine, low folate phenotype commonly observed in individuals with the MTHFR 677 TT genotype is present only among individuals with the CBS 844ins68 NN genotype [32-34]. Further, there is some evidence that interactions between these two variants may influence the risk of neural tube defects [35-38].
###end p 27
###begin p 28
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
This study had several strengths, including a large sample size and consideration of the joint effects of genetic variants within the folate metabolic pathway. In addition, the effects of both the maternal and inherited genotypes were considered, as was heterogeneity of the effects of the inherited genotype across the component CTRD phenotypes. It is of note that in this large sample, the association between CTRD risk and the inherited MTHFR A1289C genotype did not appear to differ across the various CTRD phenotypes, which provides support for the inclusion of the full range of CTRD phenotypes in studies aimed at identifying CTRD risk factors.
###end p 28
###begin p 29
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
As with all studies, this study also had limitations. Although this is the largest and most comprehensive study of CTRD and genes in the folate metabolic pathway conducted to date, it included only ten variants in nine folate metabolic genes. Further, heterogeneity within the case group may have influenced the observed associations, although results from MDR-P provide some evidence that the component CTRD phenotypes can be combined for analysis. In addition, the power to detect weak to moderate gene-gene interaction effects was low, and this limitation was further compounded by the relatively large number of interactions that were evaluated. Hence, although the observed association between CTRD and the maternal MTHFR C677T/CBS 844ins68 interaction is consistent with the biochemical consequences of this gene-gene combination, it is based on small numbers and may represent a false-positive finding.
###end p 29
###begin title 30
5. Conclusions
###end title 30
###begin p 31
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 496 499 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
The results of our study are consistent with the previous studies in this and other populations that indicate an association between the inherited MTHFR A1298C genotype and CHDs. In addition, our results suggest that this association is similar for each of the CTRD component phenotypes and, therefore, provides some support for pooling data from the component phenotypes in analyses aimed at identifying CTRD risk factors. The results of these analyses also indicate that a maternal MTHFR C677T/CBS 844ins68 interaction may be associated with the risk of CTRD in offspring. However, this finding requires confirmation in independent study samples. Hence, larger studies, which include additional folate metabolic pathway genes and a more extensive set of SNPs, are needed to more fully elucidate the role of folate in CTRD.
###end p 31
###begin title 32
Acknowledgments
###end title 32
###begin p 33
The authors would like to acknowledge Stacy Woyciechowski and Daniel Renstrom for their assistance on this project. This research was supported by Grants from the NIH/NHLBI (P50 HL74731 and R01 HL076773 to the second and the third authors). This project was also supported by Grant no. M01-RR-000240 and UL1-RR-024134 from the National Center for Research Resources.
###end p 33
###begin article-title 34
Racial and temporal variations in the prevalence of heart defects
###end article-title 34
###begin article-title 35
Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics
###end article-title 35
###begin article-title 36
Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics
###end article-title 36
###begin article-title 37
Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the "pent" design
###end article-title 37
###begin article-title 38
Seeking causes: classifying and evaluating congenital heart defects in etiologic studies
###end article-title 38
###begin article-title 39
Variants of folate metabolism genes and the risk of conotruncal cardiac defects
###end article-title 39
###begin article-title 40
Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene
###end article-title 40
###begin article-title 41
###xml 9 14 <span type="species:ncbi:9606">human</span>
Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes
###end article-title 41
###begin article-title 42
118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects
###end article-title 42
###begin article-title 43
Allowing for missing parents in genetic studies of case-parent triads
###end article-title 43
###begin article-title 44
###xml 40 45 <span type="species:ncbi:9606">human</span>
Common genetic polymorphisms affect the human requirement for the nutrient choline
###end article-title 44
###begin article-title 45
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression
###end article-title 45
###begin article-title 46
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 46
###begin article-title 47
A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
###end article-title 47
###begin article-title 48
The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia
###end article-title 48
###begin article-title 49
The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations
###end article-title 49
###begin article-title 50
Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?
###end article-title 50
###begin article-title 51
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients
###end article-title 51
###begin article-title 52
###xml 57 61 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
A common 844INS68 insertion variant in the cystathionine beta-synthase gene
###end article-title 52
###begin article-title 53
A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate
###end article-title 53
###begin article-title 54
###xml 34 39 <span type="species:ncbi:9606">human</span>
Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels
###end article-title 54
###begin article-title 55
Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables
###end article-title 55
###begin article-title 56
Case-only design to measure gene-gene interaction
###end article-title 56
###begin article-title 57
Population stratification bias in the case-only study for gene-environment interactions
###end article-title 57
###begin article-title 58
The use of case-parent triads to study joint effects of genotype and exposure
###end article-title 58
###begin article-title 59
A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting
###end article-title 59
###begin article-title 60
Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies
###end article-title 60
###begin article-title 61
MTHFR 677 C > T and 1298 C > T polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer
###end article-title 61
###begin article-title 62
###xml 31 35 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677 C > T polymorphisms on folate and homocysteine concentrations
###end article-title 62
###begin article-title 63
###xml 44 48 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Linkage disequilibrium at the cystathionine beta synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine
###end article-title 63
###begin article-title 64
###xml 117 120 <span type="species:ncbi:9606">men</span>
Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men
###end article-title 64
###begin article-title 65
Exploring gene-gene interactions in the etiology of neural tube defects
###end article-title 65
###begin article-title 66
###xml 77 82 <span type="species:ncbi:9606">human</span>
Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects
###end article-title 66
###begin article-title 67
Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population
###end article-title 67
###begin article-title 68
###xml 51 55 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects
###end article-title 68
###begin p 69
###xml 44 52 <span type="species:ncbi:9606">Children</span>
Characteristics of study cases and parents, Children's Hospital of Philadelphia, 1997-2007.
###end p 69
###begin p 70
*Conoventricular or posterior malalignment type ventricular septal defect; coarctation of the aorta was present in 16 of the case individuals with a VSD.
###end p 70
###begin p 71
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 93 101 <span type="species:ncbi:9606">Children</span>
MDR-P results (adjusted P values) for all 2-locus models of the inherited genotype and CTRD, Children's Hospital of Philadelphia, 1997-2007.
###end p 71
###begin p 72
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
*This interaction was not assessed as the two MTHFR variants are in strong linkage disequilibrium.
###end p 72
###begin p 73
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 102 110 <span type="species:ncbi:9606">Children</span>
Case-only results (unadjusted P values) for all pairwise combinations of maternal genotypes and CTRD, Children's Hospital of Philadelphia, 1997-2007.
###end p 73
###begin p 74
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
*This interaction was not assessed as the two MTHFR variants are in strong linkage disequilibrium.
###end p 74
###begin p 75
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 55 63 <span type="species:ncbi:9606">Children</span>
Maternal MTHFR and CBS 844ins68 genotype combinations, Children's Hospital of Philadelphia, 1997-2007.
###end p 75
###begin p 76
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 118 126 <span type="species:ncbi:9606">Children</span>
Relative risk of CTRD for maternal MTHFR C677T/CBS 844ins68 genotype combinations estimated by log-linear regression, Children's Hospital of Philadelphia, 1997-2007.
###end p 76
###begin p 77
*Based on the likelihood ratio test of no interaction.
###end p 77

